Lexpos News

/Lexpos News

Community Pharmacy England and LPCs complete representation changes

A series of documents have been published by Community Pharmacy England, following discussion of many of the key points and themes at regional meetings with pharmacy owners this summer. The briefings talk pharmacy owners and LPCs through key aspects of our strategy and workplans for the current year, and set out how levy monies have [...]

The post Community Pharmacy England and LPCs complete representation changes appeared first on Community Pharmacy England.

By |July 30th, 2024|Lexpos News|Comments Off on Community Pharmacy England and LPCs complete representation changes

Change to August Pharmacy First monthly threshold

The ability of pharmacy owners to achieve the thresholds for the monthly Pharmacy First payment has been a topic of great concern for pharmacy owners and Community Pharmacy England, particularly as the August increase to 20 clinical pathways got closer. We have been discussing this issue over the last few weeks with the Department of [...]

The post Change to August Pharmacy First monthly threshold appeared first on Community Pharmacy England.

By |July 30th, 2024|Lexpos News|Comments Off on Change to August Pharmacy First monthly threshold

MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/33 MDR number: MDR 113-05/24 Date issued: 30 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

By |July 30th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

3 medicines removed from HRT PPC list from 1 August 2024

Pharmacy teams should be aware that the following three HRT medicines have been discontinued and will be removed from the list of medicines covered by the HRT PPC on 1 August 2024: Bedol® 2mg tablets Climanor® 5mg tablets Clinorette® tablets As Climanor® 5mg tablets is now discontinued, the generic Medroxyprogesterone 5mg tablets will also be removed from the [...]

The post 3 medicines removed from HRT PPC list from 1 August 2024 appeared first on Community Pharmacy England.

By |July 29th, 2024|Lexpos News|Comments Off on 3 medicines removed from HRT PPC list from 1 August 2024

Last few days to complete the 2024/25 CPAF screening questionnaire

As of 29th July, 86% of community pharmacies have completed the CPAF screening questionnaire. The remaining pharmacies only have a couple of days left to complete it before the deadline of midnight on Wednesday 31st July 2024.   As a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement [...]

The post Last few days to complete the 2024/25 CPAF screening questionnaire appeared first on Community Pharmacy England.

By |July 29th, 2024|Lexpos News|Comments Off on Last few days to complete the 2024/25 CPAF screening questionnaire